231 related articles for article (PubMed ID: 29534682)
1. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.
David D; Surendran A; Thulaseedharan JV; Nair AS
BMC Cancer; 2018 Mar; 18(1):284. PubMed ID: 29534682
[TBL] [Abstract][Full Text] [Related]
2. Smurf2 E3 ubiquitin ligase modulates proliferation and invasiveness of breast cancer cells in a CNKSR2 dependent manner.
David D; Jagadeeshan S; Hariharan R; Nair AS; Pillai RM
Cell Div; 2014; 9():2. PubMed ID: 25191523
[TBL] [Abstract][Full Text] [Related]
3. Smurf2 regulates the degradation of YY1.
Jeong HM; Lee SH; Yum J; Yeo CY; Lee KY
Biochim Biophys Acta; 2014 Sep; 1843(9):2005-11. PubMed ID: 24803334
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of Smurf2, a tumor-suppressive ubiquitin ligase, in triple-negative breast cancers: involvement of the RB-microRNA axis.
Liu X; Gu X; Sun L; Flowers AB; Rademaker AW; Zhou Y; Kiyokawa H
BMC Cancer; 2014 Feb; 14():57. PubMed ID: 24485087
[TBL] [Abstract][Full Text] [Related]
5. The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2).
Kim S; Jho EH
J Biol Chem; 2010 Nov; 285(47):36420-6. PubMed ID: 20858899
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.
Du JX; Hagos EG; Nandan MO; Bialkowska AB; Yu B; Yang VW
J Biol Chem; 2011 Nov; 286(46):40354-64. PubMed ID: 21953463
[TBL] [Abstract][Full Text] [Related]
7. Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2.
Ray D; Ahsan A; Helman A; Chen G; Hegde A; Gurjar SR; Zhao L; Kiyokawa H; Beer DG; Lawrence TS; Nyati MK
Neoplasia; 2011 Jul; 13(7):570-8. PubMed ID: 21750651
[TBL] [Abstract][Full Text] [Related]
8. The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.
Dong S; Liu J; Li L; Wang H; Ma H; Zhao Y; Zhao J
Am J Physiol Cell Physiol; 2019 May; 316(5):C632-C640. PubMed ID: 30758996
[TBL] [Abstract][Full Text] [Related]
9. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells.
Fukunaga E; Inoue Y; Komiya S; Horiguchi K; Goto K; Saitoh M; Miyazawa K; Koinuma D; Hanyu A; Imamura T
J Biol Chem; 2008 Dec; 283(51):35660-7. PubMed ID: 18927080
[TBL] [Abstract][Full Text] [Related]
10. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
[TBL] [Abstract][Full Text] [Related]
12. Nedd8 targets ubiquitin ligase Smurf2 for neddylation and promote its degradation.
Shu J; Liu C; Wei R; Xie P; He S; Zhang L
Biochem Biophys Res Commun; 2016 May; 474(1):51-56. PubMed ID: 27086113
[TBL] [Abstract][Full Text] [Related]
13. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
Salah Z; Itzhaki E; Aqeilan RI
Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
[TBL] [Abstract][Full Text] [Related]
14. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
[TBL] [Abstract][Full Text] [Related]
16. DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.
Choi YM; Kim KB; Lee JH; Chun YK; An IS; An S; Bae S
Oncogene; 2017 May; 36(20):2802-2812. PubMed ID: 27941885
[TBL] [Abstract][Full Text] [Related]
17. SMURF2 facilitates ubiquitin-mediated degradation of ID2 to attenuate lung cancer cell proliferation.
Han M; Guo Y; Li Y; Zeng Q; Zhu W; Jiang J
Int J Biol Sci; 2023; 19(11):3324-3340. PubMed ID: 37497010
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
Yu L; Dong L; Li H; Liu Z; Luo Z; Duan G; Dai X; Lin Z
Oncogene; 2020 May; 39(22):4450-4464. PubMed ID: 32361710
[TBL] [Abstract][Full Text] [Related]
19. The E3 ubiquitin ligase SMURF2 stabilizes RNA editase ADAR1p110 and promotes its adenosine-to-inosine (A-to-I) editing function.
Koganti P; Kadali VN; Manikoth Ayyathan D; Emanuelli A; Paolini B; Levy-Cohen G; Blank M
Cell Mol Life Sci; 2022 Apr; 79(5):237. PubMed ID: 35403872
[TBL] [Abstract][Full Text] [Related]
20. The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
Chandhoke AS; Chanda A; Karve K; Deng L; Bonni S
Oncotarget; 2017 Mar; 8(13):21001-21014. PubMed ID: 28423498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
